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Summary
T cells recognize peptides that are bound to MHC molecules on the surface of different types
of antigen-presenting cells (APC). Antigen presentation most often is studied using T cells that
have undergone priming in situ, or cell lines that have been chronically stimulated in vitro. The
use of primed cellsprovides sufficient numbers of antigen-reactive lymphocytes for experimental
study. A more complete understanding of immunogenicity, however, requires that one develop
systems for studying the onset of a T cell response from unprimed lymphocytes, especially in
situ. Here it is shown that mouse T cells can be reliably primed in situ using dendritic cells
as APC. The dendritic cells were isolated from spleen, pulsed with protein antigens, and then
administered to naive mice. Antigen-responsive T cells developed in the draining lymphoid tissue,
and these T cells only recognized protein when presented on cells bearing the same MHC products
as the original priming dendritic cells. In contrast, little or no priming was seen if antigen-pulsed
spleen cells or peritoneal cells were injected. Since very small amounts of the foreign protein
were visualized within endocytic vacuoles of antigen-pulsed dendritic cells, it is suggested that
dendritic cells have a small but relevant vacuolar system for presenting antigens over a several
day period in situ.
T
he immunologic activity of T lymphocytes is directed
to antigens presented by MHC products on the sur-
faces ofother cells termed APC (1-4). While many cell types
are capable of generating MHC-peptide complexes and pre-
senting these to primed T cells, it is evident that the den-
dritic cell subset of APC greatly accelerates the early sensiti-
zation phase of the immune response. This has been noted
in vitro with transplantation (5-7) and viral (8, 9) antigens,
and in situ using contact (10, 11) and transplantation antigens
(12-14). Nevertheless, experimental studies of T cell sensiti-
zation in situ to antigens that require processing typically
utilize artificial adjuvants rather than viable APC. Whenever
bulk spleen cells have been used as APC in the absence of
adjuvants, it has not been possible to restrict the sensitiza-
tion to antigens in association with MHC products of the
injected cells (15, 16) . Therefore presentation in situ likely
involves host rather than injected APC.
KurtJones et al. used B cells as APC in situ to reverse
a lack of T-cell responsiveness in mice that had been suppressed
chronically with anti-P, antiserum (17). The B cells, when
given simultaneously with antigen in CFA, appeared to be
capable of priming MHC-restricted T cells in some but not
all cases. In contrast, Lassila et al. (18) reported that in a chicken
system B cells could not present antigens to T cells in situ.
Likewise, in primary antibody responses to hapten-carrier con-
jugates in vitro, dendritic cells and not B cells are required
as APC early in the immune response (19).
Here we have assessed the capacity of antigen-pulsed den-
dritic cells to sensitize the T cellsof an unprimed individual.
We find that specific priming occurs, and that the sensitized
T cells are restrictedto recognize antigen on the MHC prod-
ucts of the presenting dendritic cells. These results suggest
that dendritic cells are "nature's adjuvant:' They are capable
of delivering exogenous antigens, most likely as complexes
of peptides on surface MHC products, directly to naive T
cells in situ.
Materials and Methods
Mice. BALB/C x DBA/2 (CxD2)Fl (H-2d), C3H/HeJ (H-
2k), and (C3H x DBA/2)F1 mice, 6-12 wk old and of both sexes,
were purchased from The Trudeau Institute, Saranac Lake, NY.
Proteins. The antigens tested were spermwhale myoglobin,
conalbumin, human gamma globulin, ovalbumin (Sigma Chem-
ical Co., St. Louis, MO) and rhodamine-modified ovalbumin (Mo-
lecular Probes, Eugene, OR).
Culture Medium.
￿
For the preparation and antigen-pulsing of
dendritic cells, the medium was RPMI 1640 (Gibco Laboratories,
Grand Island, NY) supplemented with 5% FCS, 50 AM 2-ME,
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in vitro, the medium was Click's medium (Irvine Scientific, Santa
Ana, CA)supplemented with 0.5% heat-inactivated mouseserum,
50 PM 2-ME, and 20 14g/ml gentamicin.
Antigen "Pulsing"ofAPC.
￿
As will be evident in Results, it was
necessary to expose fresh rather than cultured dendritic cells to a
foreign protein to successfully charge these APC with antigen. Ad-
herent cells from a low buoyant density fraction of spleen were
prepared (20-22) and cultured overnight (12-18 h) in medium to
which 0.1 mg/ml of protein antigen was added. After overnight
culture, thedendritic cells were purified by rosetting most of the
contaminants (macrophages, Bcells) with antibody-coated erythro-
cytes (21, 22). In experiments to be reported elsewhere (23), we
have found that fresh dendritic cells purified on a FACS can be
chargedwith antigen withjust a 3-hexposure. However, the longer
overnight "pulse" (12-18 h) was used, since it simplified the
purification of the dendritic cells and improved their APC func-
tion. To ensure that thedendritic cells hadbeen successfully pulsed
with antigen, we didconventional restimulation assays usingprimed
lymph node Tcells (see Results). TheotherAPCpopulations that
were pulsed with foreign proteins were resident peritoneal cells,
maintained in Teflon beakers to reduce macrophage adherence, and
unfractionated spleen cells. In some experiments, 4 mg ofprotein
was given to mice intravenously or intraperitoneally, spleen den-
dritic cellswere isolated as described(24), and thesein vivo pulsed
APC were readministered to naive mice.
Priming with Antigenpulsed APCIn Situ.
￿
Antigen-pulsed APC
were washed at least three times in RPMI 1640 and administered
in PBSat a dose of 2-60 x 105 cells in a volume of 25-40 pl into
thefore or hind footpads. Generally, the antigen-pulsed APCwere
administered on one side, and the contralateral footpads served as
the control. The control footpads were injected with APC that
either had notbeen antigen-pulsed or were pulsed with anoncross-
reacting protein (see Results). At varying times thereafter, butusu-
ally at day 5, the draining popliteal or brachial lymph nodes were
removed, teased into a cell suspension, and challenged with an-
tigen in vitro at 1-100 lAg/ml. 3 x 105 cells were cultured in
triplicate in flat-bottomed microtest wells (No. 25860; Corning
Glassworks, Corning, NY). DNA synthesis was measured on the
3rd day after exposure to [3H]TdR (specific activity, 6.0 Ci/mM)
at 4 ACi/ml for 12-16 h. Unprimed lymph nodes never showed
a response to the antigens we studied. The cells that responded
by DNA synthesis in primed mice were shown to be primarily
CD4' Thy-1` cellsby treatment with appropriate mAb and com-
plement before the assay for DNA synthesis.
MHC Restriction ofIn Vivo Primed T Cells.
￿
C3H x DBA/2
or A x DBA/2 F, (Iak x lad) mice were primed with antigen-
pulsed dendritic cells from either parental strain. 5 d later the
draining lymph nodes were taken, and the cell suspensions were
treated with mAbJ11d anti-B cell anddendritic cell (22) andB21-2
anti-I-A plus rabbit complement (Pel-Freeze Biologicals, Rogers,
AR) to deplete lymph node APC. The cells were then cultured
at 3 x 105 cells per microtest well in triplicate with graded doses
of irradiated (1,000 rad '31Cs) parental or Fl spleen cells as APC
with or without antigen. As will be evident in the Results, re-
sponsiveness was observed primarily when antigen was presented
by the same parent that was used to prime the animals. To verify
that the response was class II MHC-restricted, blocking studies
with culture supernatants of anti-la mAbs were performed. The
mAbs were B21-2 anti-lad and 10-2.16 anti-lak, both available at
the American Type Culture Collection, Rockville, MD (TIB 229
and TIB 93, respectively).
Pinocytosis ofProteinAntigens.
￿
Rhodamine-modified ovalbumin
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proved to be a sensitive protein for visualizing pinocytosis by the
weakly endocyticdendriticcells. Uptake wasapparent afteran over-
night exposure to 0.1 mg/ml. Little or no uptake was evident at
0.02 mg/ml, or after a 2-h exposure, using fluorescence micros-
copy with aZeiss Axiomat equipped for epifluorescence. Theother
tracers which we tested, which showed less and sometimes no up-
take at thelightmicroscopic level, were FITC-dextran, lucifer yellow,
and horseradish peroxidase all at 0.1 mg/ml, thedose used to charge
the APC with antigen. The positive control for active pinocytic
activity was provided by resident macrophages in peritoneal
washouts (see Results) .
Results
ConditionsforPulsingMouseDendritic Cellswith Protein An-
tigens In Vitro. We began with sperm whale myoglobulin,
for which priorstudieshaddefinedan immunodominant re-
gion in the H-2d mouse corresponding to residues 106-118
(25, 26). Spleen adherent cells, which include dendriticcells,
macrophages, and B cells, were cultured with or withoutna-
tive myoglobin overnight (16-24 h). The dendriticcellswere
then enriched by a standard method (21, 22) and tested for
their capacity to stimulate myoglobin-primed T cells. As
shownbefore (27), dendritic cellsthat hadbeen cultured over-
night without antigenwere able to presentpeptidefragments,
but presented native protein only weakly (Table 1, compare
group3 with groups 1 and2). However, if thedendriticcells
had been exposed to protein during the overnight culture,
the antigen-pulsed APC vigorously stimulated the primed
T cells [Table 1, group 4) . Similar findings were made with
other proteins (human gamma globulin, conalbumin, and
ovalbumin), but we did not have active peptide fragments
for these antigens. Similar results also were obtained if the
dendritic cellswere cultured for 2dbefore use (Table 1, com-
pare group 7 with groups 5 and 6). However, it was noted
that the antigen pulse was best if givenduring the firstrather
than the second dayofculture(Table 1, comparegroups 8-10).
Once pulsed, the dendritic cell maintained immunogenicity
for at least aday in culture (Table 1, group 10). We conclude
that freshly isolated dendriticcells can be successfully pulsed
with a variety of soluble protein antigens in vitro, but that
it is important to administer the antigenshortly afterisolating
the dendritic cells from the spleen.
Antigenpulsed Dendritic CellsSensitizeTCells In Situ.
￿
After
exposure to one of four different proteins, as above, the den-
dritic cells were injected into the left hind foot pad; com-
panion unpulsed dendritic cells were injected into the right
side. The draining popliteallymphnodes from groups ofthree
to five mice were taken 5 d later and tested for responses in
vitro to each of three different proteins. To avoid responses
to FCS components, which were present during the time
that the dendritic cells were pulsed with antigen, thelymph
node cellswere cultured in thepresence of mouserather than
fetal calf serum.
For each protein, the lymph node draining the site of
antigen-pulsed, dendritic cell deposition developed specific
antigen responsiveness (Table 2) . If we injected two popula-
tions of dendritic cells, each pulsed with different proteins,
then thelymph node cells acquired reactivity to both antigens." Low density spleen adherent cells, which are a partially enriched population of dendritic cells (20-22), were cultured for 1 or 2 d in medium
supplemented with antigen (100 ug/ml sperm whale myoglobin; Fluka) where indicated. After culture, contaminating macrophages and B cells
were removed by rosetting with antibody-coated red cells.
No antigen, myoglobin (5 AM), or myoglobin peptide 105-118 (2.5 AM), was added to the coculture of antigen-pulsed dendritic cells and
myoglobin-primed T cells (below).
S Antigen-primed T cells were prepared as follows. Mice were primed with 5 Am of myoglobin in CFA in the footpads. Brachial and/or
popliteal lymph nodes were taken 5 d later and cell suspensions were prepared by teasing the nodes with forceps. The cell suspensions were
cultured at 5 x 106 cells/well in 24-well trays in 1.5 ml Click's medium supplemented with 0.5% mouse serum, 2 MM L-glutamine, 50 AM
2-ME, and 5 AM myoglobin. 10 d later the contents of the flask were applied to Ficoll (Sigma) columns to collect viable lymphoblasts. By
using T cells that had been expanded in vitro, rather than fresh lymph node cells, we could obtain populations that responded strongly to re-
stimulation with specific antigen on dendritic cells, without the syngeneic mixed leukocyte reaction that typically elevates background DNA
synthesis when lymph node cells are cultured with unpulsed dendritic cells.
11 3 x 104 myoglobin-primed T blasts (see S) were cultured with graded doses of dendritic cells (see ') [3H]TdR was added at 48-64 h to
measure DNA synthesis. Data are mean cpm [3H]TdR uptake x 10-3 for triplicate wells; standard deviations were <10% of the mean. The
experiment was repeated once with similar results.
In these latter experiments, there was some development of
antigen reactivity in the nondraining lymph node (Table 2,
last pair of antigens).
In experiments that are not shown, the antigen-reactive
lymph node cells were CD4+ T cells primarily, since >80%
of the reactivity could be eliminated with either anti Thy-1
or anti-CD4 mAb and complement. The sensitizing capacity
of dendritic cells was reproducible, in that individual mice
each gave responses of comparable magnitude.
In kinetic studies, the draining lymph node cells became
responsive over a 5-d period to the specific protein that had
been used to pulse the injected dendritic cells (Fig. 1). An-
tigen specificity was maintained at all time points, i.e., if the
left foot pad had been injected with dendritic cells pulsed
with human gamma globulin, the left popliteal node devel-
oped specific responsiveness to human gamma globulin but
not to other proteins (Fig. 1, left). Likewise, the right popliteal
node developed responsiveness to the protein used to pulse
the dendritic cells that were injected into the right food pad
(Fig. 1, right).
When primed mice were rechallenged with antigen-pulsed
dendritic cellsbut in a site distal to that used for the original
priming (front vs. hind foot pad), the lymph node draining
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this second site showed an accelerated or "memory" type re-
sponse to the appropriately pulsed dendritic cells (Fig. 2).
Responsiveness to antigen was apparent on the second day
and virtually disappeared by the third.
Dendritic cells were also charged with a 2-h pulse of pro-
tein antigen in vivo as recently described (24). The dendritic
cells were purified from the spleen using the FACS and in-
jected into naive mice. Specific priming to the protein that
originally had been given systemically to the dendritic cell
donor was then observed (Table 3). We conclude that den-
dritic cells that had been pulsed with protein antigen in vitro
or in vivo are capable of sensitizing CD4+ T cells from
naive mice to that protein.
APC Requirementsfor SuccessfulPriming In Situ.
￿
Dendritic
cells were compared with two standard populations that have
been used in many studies of antigen presentation in vitro.
These were suspensions from spleen (a rich source of B lym-
phocytes) and peritoneal cavity (a rich source ofmacrophages
and CD5+ B cells). The populations were pulsed with an-
tigen for either 3 h or for 18 h in culture and administered
in graded doses of 8 x 105 to 5 x 106 cells to the footpads
of naive recipients (Table 4). Spleen cells were marginally effec-
tive, in that only the highest dose of 6 x 106 cells induced
Table 1. Conditions for Pulsing Dendritic Cells with a Foreign Protein In Vitro
DNA synthesis by antigen-primed T cellss
to graded doses of dendritic cellsll
Culture of dendritic cells Antigent during
Group before use as APC" the APC-T coculture 3 x 104 10, 3 x 103 103
1 0-24 h, no antigen None 3.9 1.9 0.8 0.2
2 0-24 h, no antigen Myoglobin 7.6 1.6 0.5 0.2
3 0-24 h, no antigen Myopeptide 45.9 20.2 6.9 1.2
4 0-24 h, myoglobin None 91 .6 37.9 10 .8 4.2
5 0-48 h, no antigen None 3.6 1.4 0.7 0.3
6 0-48 h, no antigen Myoglobin 0.3 0.6 0.3 0.3
7 0-48 h, no antigen Myopeptide 39.2 18.2 4.7 0.7
8 0-48 h, myoglobin None 81 .8 27 .3 8.9 3.2
9 0-24 without myo, 24-48 with myo None 15.0 4.4 1.7 0.7
10 0-24 with myo, 24-48 without myo None 88.5 27 .6 9.8 4.0Table 2 .
￿
Dendritic
cells
that Are Pulsed with a Protein Antigen In Vitro Specifically Prime Animals to that Protein In Situ
DNA synthesis after challenge with
Low density spleen adherent cells were cultured for 1 d with or without antigen, after which macrophages and B cells were depleted (21, 22) .
2 x 105 dendritic cells were injected in the foot pads of groups of four mice. 5 d later, the draining popliteal nodes were taken and cell sus-
pensions were prepared by teasing with fine forceps. 3 x 105 primed lymph node cells were cultured in flat-bottomed microtiter wells
without antigen, or with the indicated antigens at 100 or 10 Ag/ml. (3H]TdR was added at 44-60 h to measure DNA synthesis.
Table 3.
￿
Priming ofAntigen Specific Lymph Node T Cells Using Dendritic Cells that Have Been Pulsed with Antigen
In Vitro or In Vivo
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` 5 d after priming with dendritic cells in the front footpad, brachial lymph node cells were prepared and restimulated in culture with the in-
dicated antigen. DNA synthesis was measured on the third day.
t Low density spleen adherent cells were pulsed with 100 ttg/ml of protein overnight . Dendritic cells were then purified by depleting FcR'
cells (21, 22).
S Mice were given 4 mg conalbumin i.v. 2 h later, the spleens were taken, and dendritic cells were isolated using the FACS and the N418
mAb to murine CDIIc (24). N418 primarily reacts with dendritic cells in mouse spleen (23) .
Popliteal
node
DC pulsed
with: No Ag
Conalbumin
100 10
Myoglobin
100 10
Hu x gamma
globulin
100 10
cpm x 10-3
Right No Ag 0.4 0.7 0.4 0.7 0.6 3.2 2.0
Left Conalbumin 0.3 126.1 92 .7 1.3 0.8 3.4 0.9
Right Myoglobin 0.2 0.4 0.2 32 .3 33 .9 1.4 0.9
Left No Ag 0.2 0.5 0.3 0.3 0.4 1.9 0.1
Right HGG 0.2 0.5 0.3 0.2 0.4 27.4 18 .0
Left No Ag 0.4 0.8 0.7 0.7 0.4 2.6 2.3
Right Conalbumin + Myoglobin 0.5 58 .7 18 .5 40 .0 42.7 3.7 2.4
Left HGG 0.2 0.3 0.2 0.3 0.3 18.6 11.6
Right Conalbumin 0.7 99 .6 79 .5 2.2 1.2 19.6 8.7
Left Myoglobin+HGG 0.7 8.7 4.5 73 .8 62 .9 119.4 104.6
Right/left No DC 0.1 0.2 0.2 0.2 0.2 0.6 0.3
DNA synthesis of primed lymph
boosted in vitro with'
node
Conalbumin (Fig/ml) BSA OVA
Dendritic cells [2 x 105] used
to prime brachial nodes No Ag 100 10 1 100 100
cpm x 10-'
In vitro pulses
Myoglobin 0.1 0.1 - - 0.9 -
Conalbumin 0.4 155.4 148.8 119.3 3.3 1.1
Conalbumin pulse + 25 Pg soluble Ag in paw 0.4 161.8 145.3 124.1 4.8 0.3
In vivos
Conalbumin 0.3 68.7 45 .5 22.1 1.5 1.0n
X
v
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Left, primed with HGG-DC
￿
Right, primed with conalb-DC
Days after priming with dendritic cells
Figure 1 .
￿
Kinetics of the primary response to antigen-pulsed den-
dritic cells. Low density spleen adherent cells were cultured with or
without 100 l~g/ml of the indicated proteins for 24 h. The cells were
washed and 3 x 105, Fck- dendritic cells were injected into each
foot pad. At the indicated time points, the draining popliteal and
brachial lymph nodes were taken and cultured with the indicated pro-
teins at 100 ug/ml in Click's medium supplemented with 0.5%p
mouse serum. DNA synthesis was measured on the third day. Lymph
node cells that were primed with dendritic cells that had not been
pulsed with antigen did not exhibit an antigen response (not shown,
but see Table 2). The experiments were repeated twice with similar
results.
a low level of responsiveness in the draining lymph node.
Peritoneal cells were ineffective at all doses. Inocula of 2 and
5 x 105 dendritic cells had similar effects in situ, and the
minimum dose capable of inducing some responsiveness was
3-8 x 104 dendritic cells (Table 4).
MHC Restriction of T Cells Primed bY Antigenpulsed Den-
dritic Cells. The finding that antigen-pulsed dendritic cells
could prime naive animals to that antigen couldbe explained
by a unique ability of dendritic cells to stimulate T cells directly
in vivo, or alternatively, to transport antigens that were
presented subsequently by host APC. The two possibilities
could be distinguished by assessing whether the T cell sen-
sitizationprocess was restricted to antigens presented on the
injected vs. host dendritic cells. We primed Fl mice with
antigen-pulsed dendritic cells from either parental strain and
tested if the primed Fl T cells could only be boosted with
spleen APC from the original parent. It is known that most
clones of T lymphocytes in an Fl animal are restricted to an-
tigens presented by one or the other parental MHC (28, 29).
We used AxDBA/2 (H-2' x H-2d) or C3HxDBA/2 (H-2k
x H-2d) Ft recipients and primed with antigen-pulsed den-
dritic cells from each parental strain. 5 d later the Fl lymph
node cells were isolated, depleted ofendogenous APC by treat-
ment with anti-Ia andJ11d mAb and complement, and chal-
lenged with APC from the Fl or from either parent.
The Fl T cells responded vigorously to antigen rechal-
lenge in vitro with Ft APC (Table 5) . If parental strain APC
were used, the rechallenge was far more effective with APC
from the same parental strain that was used to sensitive the
local node (Table 5). To show that the responses were re-
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￿
Secondary responses in mice that had been primed with
antigen-pulsed dendritic cells. Conalbumin-pulsed dendritic cells (DC)
were injected into the right hind foot pad as in Fig. 1, while the left
hind foot pad received dendritic cells that were not pulsed with
conalbumin. At the indicated time points (left), the draining lymph
nodes were taken and boosted with protein antigen in vitro. Note
that the primary response peaks at day 5 and subsides by day 7-9, as
in Fig. 1. Companion groups of mice were then boosted on day 12
with antigen-pulsed DC, but in the right front foot pad to look for
a secondary response (right). The experiment was repeated twice with
similar results.
stricted to the classII MHC molecules ofthe sensitizing den-
dritic cells, we verified that a mAb to I-Ad blocked the re-
stimulation of Fl T cells primed with H-2d APC but not
with H-22 APC, while mAb to I-Ak blocked presentation
by H-2k APC but not H-2d APC (Table 6).
Visualization of Antigen Uptake in Dendritic Cells.
￿
Since
one pathway for antigen presentation likely involves endocy-
tosis of the foreign protein followed by proteolysis and for-
mation of peptide-MHC complexes (4), we monitored the
extent to which dendritic cells could accumulate a protein
that we could visualize, rhodamine-modified ovalbumin.
When dendritic cells were pulsed overnight in 0.1 mg/ml
of protein, it was evident that each cell had a small number
of fluorescent granules, usually close to the nucleus (Fig. 3,
left). Macrophages in contrast were much more heavily la-
beled after exposure to rhodamine-ovalbumin (Fig. 3, right).
These results suggest that the strong APC function of den-
dritic cells in situ is associated with the accumulation ofonly
small amounts of the foreign protein.
To verify that the rhodamine tracer that was being visual-
ized in the above experiments was in fact relevant to im-
munogenicity in situ, we charged dendritic cells with
rhodamine-modified ovalbumin and administered the cells to
mice. 5 d latercells from the draining lymph node were tested
for antigen responsiveness. Interestingly, responsiveness de-
veloped in a dose-dependent manner (Fig. 4, left) but it was
specific for the conjugate rather than the free ovalbumin car-
rier (Fig. 4, right). Therefore, the rhodamine group that we
were monitoring in the uptake studies above (Fig. 3) was
relevant to the antigen-specific sensitization that was occur-
ring in situ.
Several features ofdendritic cells help explain the sensitizing
function of these APC in situ (30). One is their capacity toTable 4.
￿
Dendritic Cells Are Specialized to Present Antigens In Vivo
Exp.
2
capture and retain antigens, a feature that seems to be short-
lived in culture (Table 1) (27). Another is their capacity to
form stable conjugates with resting, antigen-specific T cells
and induce the development of functional T lymphoblasts
(31-33). A third feature is the ability to home via the lymph
and the blood (34-36) to the T-dependent areas oflymphoid
organs. These functions together should allow the antigen-
pulsed dendritic cell to select clones of specific T cells from
the recirculating pool (37).
The number of dendritic cells that were effective in our
experiments, 1-3 x 105, is not large when other variables
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Three different populations of APC were exposed to 100 ug/ml of myoglobin for 16 h (Exp. 1) or conalbumin (Exp. 2), washed, and ad-
ministered into the footpads of naive mice at the indicated doses. 5 d later the draining lymph nodes were taken, and the cell suspensions
were restimulated with antigens as shown. Data are cpm [3H]TdR uptake x 10-3 at 48-60 h. Data are not shown for APC that were not
pulsed with antigen before administration to mice, since the proliferative responses were all 0.3 or less.
are considered. The efficiency with which these cells leave
the injection site and home to the draining lymph node may
be very small, since Kupiec-Weglinski et al. (34) reported that
only 1-2% of a dose of "'In-labeled dendritic cells were re-
tained within the draining lymph node. This means that a
few thousand dendritic cells may carry out the sensitization
of T cells reported here. A similar conclusion was reached
in studies of pancreatic islet transplantation. There, a max-
imum of 2,000-4,000 dendritic cells seemed responsible for
sensitizing mice across an MHC barrier (13). The efficiency
of these APCs likely relates to the fact that they home to
Myoglobin-pulsed APC used
to prime in vivo
Cell type Number of cells No Antigen
Proliferation of primed lymph node cells with
Myoglobin
5 /Am 0.5 lAm
Conalbumin
100 hg/ml
Spleen cells 5 x 106 0.1 5.6 0.8 0.2
2x106 0.1 _2.1 0.2 0.2
8 x 105 0.1 0.1 0.1 0.2
Dendritic cells 5 x 105 0.1 32 .5 28.1 0.3
2x105 0.1 29.9 17.6 0.1
8 x 10° 0.1 4.2 0.6 0.1
Peritonal cells 2 x 106 0.1 0.1 - 0.1
8x105 0.1 0.1 0.1 0.1
None 0.1 0.1 0.1 0.1
Conalbumin-pulsed APC
used to prime in vivo
Cell type Number of cells No Antigen
Proliferation
100
of primed lymph node cells
Conalbumin (fcg/ml)
10 1
with
Ovalbumin
100
Spleen cells 2 x 106 0.3 99-8 6.3 2.0 0.2
1 x 106 0.3 _2.1 0.5 0.2 0.2
5x105 0.3 0.3 0.3 0.2 0.2
2.5 x 105 0.3 0.3 0.2 0.2 0.2
Dendritic cells 5 x 105 0.3 56.3 54.2 19.6 0.3
2.5 x 105 0.3 47.2 40.1 12 .1 0.3
Peritonal cells 2 x 106 0.2 0.4 0.3 0.3 0.2
1 x 106 0.2 0.3 0.3 0.2 0.2
5 x 105 0.2 0.3 0.2 0.2 0.2
2.5 x 105 0.2 0.2 0.2 0.2 0.2Table 5.
￿
Primed F, T Cells Are Restricted to the Parental Strain of the Dendritic Cells Used in Priming
F, Mice (Iakxd) were primed with 3 x 105 dendritic cells (DC) that had been pulsed with 100 ug/ml of conalbumin. The dendritic cells were
from either parental strain. 5 d later, the lymph nodes were taken and cell suspensions were prepared by teasing with fine forceps. These sus-
pensions were treated with B21-2 anti-la, andJ11d mAb and complement to deplete endogenous APC, and then plated at 3 x 105 cells in
flat-bottomed microtiter wells in Click's medium with 0.5% mouse serum. Irradiated spleen cells (1,500 rad 137Cs) from either parental strain,
or the F, strain, were then added at the indicated doses as a source of APC. Conalbumin was (+Ag) or was not (- Ag) added to the cul-
tures at 100 tcg/ml. DNA synthesis was measured at 44-60 h.
Table 6.
￿
Priming by Antigenpulsed Dendritic Cells In Vivo is MHC-restricted
* 2 x 105 dendritic cells, pulsed with conalbumin, were injected into CM x DBA/2 F, [H-2k x H-2d] mice. 5 d later, lymph nodes were
treated with antibodies to Ia and J11d + complement to deplete endogenous APC. 3 x 105 T cells were then cultured per well. The experi-
ment was repeated once with similar results.
t 3 x 105 spleen cells from the indicated strains were irradiated (137Cs, 1,000 rad) and added to the primed T cells.
S DNA synthesis was measured by adding f3H]TdR at 66-72 h. Conalbumin was added in all the experimental cultures that are shown, since
proliferation in the absence of antigen was <1 x 103 cpm. The mAbs tested for blocking activity were GK1.5 otCD4, 10-12.16 al-Ak, and
B21-2 ad-Ad .
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DNA synthesis by F, T cells
Exp.
Spleen APC used
F, T cells in
Strain
to boost
vitro
Dose
Primed with
lat DC
- Ag +Ag
Primed with
lad DC
-Ag +Ag
cpm x 10 -3
A: A x DBA/2 F, T cells A x DBA/2 3 x 105 0.6 11 .4 0.3 11.8
[Iakxd]
A 3 x 105 0.5 22.4 0.1 0.1
[lak] 5 x 105 0.8 29.6 0.3 0.6
BALB/C 3 x 105 0.3 2.7 0.2 22.9
x DBA/2 5 x 105 0.4 3.6 0.6 65.4
[Iadxd]
B: C3H x DBA/2 F, T cells C3H x DBA/2 1.25 x 105 0.2 14 .7 0.3 58.2
[lakxd] 2.50 x 105 0.6 21.8 0.5 73.0
5 x 105 1.1 25.0 3.4 67.1
BALB/C 1.25 x 105 0.2 0.5 0.2 46.7
x DBA/2 2.50 x 105 0.8 1.3 0.9 76.7
[ladxd] 5 x 105 2.0 2.2 2.5 69.0
C3H 1.25 x 105 0.1 13.3 0.4 0.8
[Ia'] 2.50 x 105 0.4 31.6 1.2 1.4
5 x 105 1.8 26.2 2.9 3.4
Strain of dendritic
cells used to prime
OH x D2 F, T cells`
Strain of spleen
used to present
antigen in vitrot no Ab
DNA synthesis in presence ofa
ceCD4 cdak aIad
cpm x 10-3
C3H, H-2k C3H, H-2k 55 .9 8.5 11 .7 42.6
C3H, H-2k 12.5 1.1 3.2 10.1
BALB/C x DBA/2, H-2d BALB/C x DBA/2, H-2d 155.5 12 .0 128.0 23.8
C3H x DBA/2 86 .2 9.0 41 .7 12.9
(II-2kxd)Figure 3 .
￿
Detection of endocytic activity by antigen-pulsed den-
dritic cells . Low density spleen adherent cells were cultured overnight
in 0 .1 mg/ml of rhodamine-modified ovalbumin. The FcR - dendritic
cells were enriched and attached to glass slides coated with poly-L-
lysine (21) . The dendritic cells (top) were uniform in cytologic appear-
ance (left) and each contained small numbers of rhodamine-labeled
granules. In parallel, peritoneal cells were also exposed RITC-OVA.
The large macrophages (bottom, arrows), as verified by strong indirect im-
munofluorescent staining with mAb to the M1/70 CD11b antigen,
were intensely labeled with the endocytic tracer (right) . x300 .
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an optimal site in the lymphoid tissue and are each capable
of binding and activating large numbers ofT cells even with
relatively small amounts of ligand on the dendritic cell sur-
face (38) .
Since the endorytic apparatus may provide an important
route for the processing and presentation of exogenous an-
tigens (4), it is of interest that the poorly endorytic dendritic
cell (Fig . 3) is nonetheless extremely active in antigen pre-
sentation . This suggests to us that the endocytic apparatus
of dendritic cells may be specialized to present antigens,
whereas in macrophages, the bulk of the endorytic activity
results in antigen clearance and degradation (39) . In the ex-
periments described here, it is formally possible that non-
dendritic cells in the adherent spleen preparation were pro-
cessing and regurgitating peptides onto dendritic cellMHC
molecules, but in a recent study (24), we presented evidence
that such a phenomenon is undetectable in our cultures . In
addition, we have also prepared highly enriched populations
ofdendritic cells fresh from spleen, using the FACS, and found
them to be potent APC for priming T cells in situ (23) .
Once CD4+ or CD8+ T cells pass a control point that
involves activation by dendritic cells, the sensitized T cells
efficiently interact with other types ofAPC to carry out var-
ious effector functions that are critical for T cell-mediated
immunity. For example, CD4+ T blasts that are induced by
dendritic cells can interact in an antigen-specific way to make
B lymphocytesgrow and respond to B cell stimulating factors
(40), and to make macrophages synthesize IL-1 (41, 42) .
CD8+ T blasts that are induced by dendritic cells can kill
other APC as targets (43, 44) . These "effector" aspects of
theimmune responsemay be restricted to inflammatory sites
in situ, given the evidence that sensitized T cells that are pro-
duced in lymphoid tissues emerge into the lymph (45) and
can move via the blood stream to inflammatory sites (46, 47) .
It is of interest that dendritic cells are not known to have
any effector or antigen elimination functions, in contrast to
other APC, such as B cells and macrophages which can re-
5x10.
of RITC-OVA pulsed
dendritic cells
2x10'
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Figure 4 .
￿
Rhodamine-ovalbumin (RITC-
OVA)-pulsed dendritic cells prime mice in situ .
Low density spleen adherent cells were ex-
posed to graded doses of RITC-OVA (left) or
to 0 .1 mg/ml RITC-OVA (right) for 16 h, and
then the dendritic cells were purified and in-
jected at a dose of 3 x 105 into fore and hind
foot pads (left) or in graded doses (right) into
groups of three mice. 5 d later the draining
lymph nodes were taken and boosted with
graded doses of RITC-OVA (left) or RITC-
OVA vs . other proteins (right) . Only the data
with 100 ug/ml protein are shown on the
right, with the popliteal and brachial nodes in
open and closed symbols, respectively.
[3H]TdR uptake was measured at 48-60 h .lease antibody or kill microorganisms. The specialized role
of dendritic cells seems to be to sensitize T lymphoblasts,
which then interact with other APC.
Extracorporeal pulsing ofantigens onto dendriticcells may
provide a new approach to immunization in situ, a goal that
previously could be approached only empirically with adju-
vants. By using dendriticcells as a natural adjuvant, onehas
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